Skip to content

Comprehensive basic research to elucidate the glaucoma pathology

Comprehensive basic research to elucidate the glaucoma pathology - Comprehensive basic research to elucidate the glaucoma pathology

Status
Unknown
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000023677
Enrollment
500
Registered
2016-08-18
Start date
2016-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glaucoma

Interventions

None listed

Sponsors

Department of Ophthalmology, Tohoku University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Surgical patients who will undergo glaucoma surgery(trabeculectomy, trabeculotomy, trabecutome, etc) or cataract surgery. 2.Performance Status: 0 ~ 4. 3.Patients who are 20 years of age or more. 4.Patients who understood and signed letter of consent.

Exclusion criteria

Exclusion criteria: 1.Patients undergoing the treatment for malignant tumor. 2.Patients undergoing hemodialysis. 3.Patients with severe systemic disease. 4.Patients who are inadequate for this study on the based on physician's discretion.

Design outcomes

Primary

MeasureTime frame
[Aqueous humor, blood, Urine] 1.Abundance of nucleic acid, protein, lipid, metabolite, etc 2.Abundance of biologically active substance(cytokine, prostaglandin, endothelin, etc) 3.Abundance of trace metal(Zinc, Mercury, etc) 4.Comprehensively Profile of autoantibody 5.Transcript abundance [Ocular tissue(sclera, Schlemm's canal, iris, trabecular meshwork)] 1.Abundance of nucleic acid, protein, lipid, metabolite, etc 2.Abundance of biologically active substance(cytokine, prostaglandin, endothelin, etc) 3.Abundance of trace metal(Zinc, Mercury, etc) 4.Comprehensively Profile of autoantibody 5.Transcript abundance 6.Abundance of glycosaminoglycan and glycosaminoglycan-degrading enzyme 7.Evaluating the tissue structure [Ocular tissue(tenon's fibroblast cells)] 1.Abundance of nucleic acid, protein, lipid, metabolite, etc 2.Abundance of biologically active substance(cytokine, prostaglandin, endothelin, etc) 3.Transcript abundance 4.Evaluating cell formation, cell proliferation and cell contraction In addition to the above, the relationship beteween above the factor and clinical information(age, sex, visual acuity intraocular pressure, visual field, etc).

Countries

Japan

Contacts

Public ContactYu Yokoyama

Tohoku University Graduate School of Medicine Department of Ophthalmology

yu-yokoyama@oph.med.tohoku.ac.jp81-22-717-7294

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026